Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ovalle

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Diabetes Research and Clinical Practice|August 21, 2010
Clinical approach to the patient with diabetes mellitus and very high insulin requirementsF Ovalle
Diabetes Care|May 20, 1999
Troglitazone's effect on lipoprotein(a) levelsF Ovalle, D S Bell
Diabetes Care|June 17, 2000
Late-onset troglitazone-induced hepatic dysfunctionD S Bell, F Ovalle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 6, 2001
Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapyD S Bell, F Ovalle
Diabetes Care|November 5, 1998
Troglitazone interferes with gemfibrozil's lipid-lowering actionD S Bell, F Ovalle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
C-Peptide utilization in clinical practice: effect on treatment and outcome of diabetes in a series of casesD S Bell, F Ovalle
Diabetes Care|June 18, 1999
Gastroparesis cured by gastrectomyD S Bell, F Ovalle
Diabetes Care|November 5, 1998
Metformin lowers lipoprotein(a) levelsD S Bell, F Ovalle
Lancet (London, England)|November 24, 1999
Hormone replacement therapy and serum uric acidF Ovalle, D S Bell
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 26, 2001
Use of soy protein supplement and resultant need for increased dose of levothyroxineD S Bell, F Ovalle
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Diabetes Research and Clinical Practice|August 21, 2010
Clinical approach to the patient with diabetes mellitus and very high insulin requirementsF Ovalle
Diabetes Care|May 20, 1999
Troglitazone's effect on lipoprotein(a) levelsF Ovalle, D S Bell
Diabetes Care|June 17, 2000
Late-onset troglitazone-induced hepatic dysfunctionD S Bell, F Ovalle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 6, 2001
Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapyD S Bell, F Ovalle
Diabetes Care|November 5, 1998
Troglitazone interferes with gemfibrozil's lipid-lowering actionD S Bell, F Ovalle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
C-Peptide utilization in clinical practice: effect on treatment and outcome of diabetes in a series of casesD S Bell, F Ovalle
Diabetes Care|June 18, 1999
Gastroparesis cured by gastrectomyD S Bell, F Ovalle
Diabetes Care|November 5, 1998
Metformin lowers lipoprotein(a) levelsD S Bell, F Ovalle
Lancet (London, England)|November 24, 1999
Hormone replacement therapy and serum uric acidF Ovalle, D S Bell
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 26, 2001
Use of soy protein supplement and resultant need for increased dose of levothyroxineD S Bell, F Ovalle
Pageof 5